Final results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...

The company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...

The analysis of latest data on efficacy is much less than the previous interim analysis announced by the company which was based on data fr...

The company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...

The US multinational pharmaceutical and biotechnology firm further announced that its experimental antiviral pill to treat COVID-19 can cut...

In the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered alon...

These protease inhibitors are a class of antiviral drugs that prevent viral reproduction by selectively binding to viral enzymes and blocki...

Standardised Ayurveda formulations provided by AVS in Kottakkal would be tested on the lab-grown coronavirus in the cell culture system, th...

Scientists at National Centre for Veterinary Type Cultures have a unique collection of over 100 small molecule chemical inhibitors that are...

Glenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...

On Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...

In a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...

However, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...

"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...

"FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not r...

Avifavir is Russia’s first COVID-19 drug and has shown high efficacy in treating patients with coronavirus during clinical trials. Avifavir...

Mumbai-based BDR Pharma, which makes anti-HIV and Hepatitis C medication, and LASA Supergenerics, an active pharmaceutical ingredient maker...